Clinical Validation of IsoPSA™, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate Cancer-Reference-Cited by-同舟云学术

Clinical Validation of IsoPSA™, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate Cancer

Published:2019-06 Issue:6 Volume:201 Page:1115-1120
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Stovsky Mark¹²,Klein Eric A.¹,Chait Arnon²,Manickam Kannan³,Stephenson Andrew J.¹,Wagner Mathew⁴,Dineen Martin⁵,Lotan Yair⁶,Partin Alan⁷,Baniel Jack⁸,Kestranek Aimee²,Gawande Prasad²,Boris Zaslavsky ²

Affiliation:

1. Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio

2. Cleveland Diagnostics, Inc., Cleveland, Ohio

3. Chesapeake Urology Associates, Baltimore, Maryland

4. Kaiser Permanente Northwest, Clackamas, Oregon

5. Advanced Urology Institute, Daytona Beach, Florida

6. University of Texas Southwestern Medical Center, Dallas, Texas

7. The Brady Urological Institute, The Johns Hopkins University, Baltimore, Maryland

8. Rabin Medical Center, Petah-Tikva, Israel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of Solvent Interaction Analysis Signatures with Thermodynamic Properties and In Silico Calculations of the Structural Effects of Point Mutations in Two Proteins;International Journal of Molecular Sciences;2024-09-06

2. Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer;Prostate Cancer and Prostatic Diseases;2024-06-10

3. Aqueous two-phase systems as multipurpose tools to improve biomarker analysis;Separation and Purification Technology;2023-07

4. Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSA;Urology;2023-06

5. The performance and limitations of PCA3, TMPRSS2:ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics;Clinical Biochemistry;2023-06